Houston Methodist is among the investors in an $80 million funding round for ambient AI company Apella.
The eight-hospital system joined the series B investment, which was led by venture capital firm HighlandX, after deploying the startup’s machine learning and computer vision capabilities in more than 200 operating rooms.
“We saw the technology’s impact on our clinical and operation systems during our initial 36-room pilot and have now scaled the technology enterprisewide,” said Roberta Schwartz, PhD, executive vice president and chief innovation officer at Houston Methodist, in a Jan. 8 Apella news release.
Apella’s other health system partners include Charleston, S.C.-based MUSC Health and Tampa (Fla.) General Hospital.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
